News | Magnetic Resonance Imaging (MRI) | September 14, 2018

Philips Launches Ingenia Ambition X 1.5T MR

Ingenia Ambition X combines fully sealed BlueSeal magnet technology and workflow innovations for a step-change in productivity

Philips Launches Ingenia Ambition X 1.5T MR

September 14, 2018 — Philips announced the launch of the Ingenia Ambition X 1.5T magnetic resonance imaging (MRI) scanner. It is the latest advance in the Ingenia MRI portfolio, which comprises fully-digital MRI systems, healthcare informatics and a range of maintenance and life cycle services for integrated solutions that empower a faster, smarter and simpler path to enabling a confident diagnosis. The first commercial installation of the Ingenia Ambition X was recently completed at Spital Uster Hospital, a major provider of extended primary healthcare in the canton of Zurich, Switzerland. The Ingenia Ambition X is CE marked and has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

In radiology, meeting the need for high productivity and an improved patient experience while ensuring excellence in imaging can be daunting. The perception is often that MR represents a trade-off between productivity and image quality. The Ingenia Ambition X provides what Philips calls leading-edge MRI capabilities while helping to increase overall productivity, combining its BlueSeal magnet with innovations that can help reduce downtime, enable single-operator workflow and speed up exam times by up to 50 percent.

Incorporating Philips' BlueSeal fully-sealed magnet, the Ingenia Ambition X is the world's first MR system to enable helium-free operations [3], reducing the chance of potentially lengthy and costly disruptions, and virtually eliminating dependency on a commodity with an unpredictable supply. The fully-sealed system does not require a vent pipe and is around 900 kg lighter than its predecessor, significantly reducing the siting challenges presented by conventional magnets and lowering construction costs.

"We are very proud to be the first hospital in the world to offer this new cutting-edge, resource-friendly MRI technology to our patients," said Andreas Steinauer, M.D., chief radiologist at Spital Uster Hospital, Switzerland. "With the new Philips Ingenia Ambition X our patients can have the best of two worlds: leading MRI technology with a smaller footprint. This new leaner platform will allow more sites to deliver advanced MRI technology to their patients, helping to improve patient care."

The Ingenia Ambition X includes a range of new features that combine to deliver a step-change in productivity, according to Philips. With Philips' EasySwitch solution, the BlueSeal's magnetic field can be easily turned off if an item becomes stuck in the bore. Once the problem is resolved, an in-house or Philips technician can initiate an automated ramp-up to bring the magnet back to field, minimizing operational downtime. A conventional MR can require two staff to manage daily operations. The Ingenia Ambition X combines guided patient setup and Adaptive Intelligence-driven SmartExam analytics for automatic planning, scanning and processing. This frees up time to enable a single operator to manage the full scan from the patient's side with just a single touch of a button.

Philips Compressed SENSE is an advanced acceleration application that reduces exam times by up to 50 percent. In addition, Philips VitalEye is a unique approach to detecting patient physiology and breathing movement. VitalEye technology and algorithms intelligently extract signs of breathing – allowing routine exam set-up time to occur in less than a minute, even for less experienced operators. Together, these innovations help to standardize and speed up workflow, allowing clinicians to focus on the patient.

Read the article "Miami Cardiac and Vascular Institute Implements Philips Ingenia Ambition X 1.5T MRI"

For more information: www.usa.philips.com/healthcare

Related Content

Doctors say they should be making medical decisions with patients, not insurance carriers and outline principles for noninvasive testing
News | Cardiac Imaging | September 23, 2021
September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by
GE has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

Getty Images

News | Radiology Business | September 23, 2021
September 23, 2021 — GE has entered into an
This study shows that thanks to deep learning analysis applied to digitized pathology slides, artificial intelligence can classify patients with localized breast cancer between high risk and low risk of metastatic relapse in the next five years.

Getty Images

News | Artificial Intelligence | September 22, 2021
September 22, 2021 — The RACE AI study conducted by Gustave...
The development of new research guidelines for interventional oncology that standardize treatment outcomes and the reporting of data represents a major step forward for an increasingly important medical subspecialty, according to a report in Radiology.

Getty Images

News | Radiation Oncology | September 21, 2021
September 21, 2021 — The development of new research guidelines for interventional oncology that standardize treatmen
HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed research recently published in the journal Cancers has demonstrated the ability of its radiomics technology to identify biomarkers that predict whether patients with lung adenocarcinoma would benefit from immunotherapy.

Semi-automatic lesion identification: (A) Manual ROI indication. In blue, it is possible to observe the axes that cross the lesion manually delineated by the radiologist on a plane of the MPR. The intensity of the lesion boundary (estimated) is represented with a red outline. (B) Additional axes can be dragged onto other orthogonal MPR views. From left to right, it is possible to observe the initial long axis outlined by the radiologist and the 2D contours on the axial, coronal and sagittal views of the lesion used as a starting point for the RPM algorithms. (C) Resulting 3D contour of the lesion (in blue).

News | Radiomics | September 21, 2021
September 21, 2021 —  HealthMyne, a pioneer in applied radiomics, announced today that peer-reviewed ...
An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging.

An illustration based on simulations by Rice University engineers shows a gadolinium ion (blue) in water (red and white), with inner-sphere water -- the water most affected by the gadolinium -- highlighted. The researchers’ models of gadolinium in water show there’s room for improvement in compounds used as contrast agents in clinical magnetic resonance imaging. Illustration by Arjun Valiya Parambathu

News | Magnetic Resonance Imaging (MRI) | September 20, 2021
September 20, 2021 — ...
News | Breast Imaging | September 20, 2021
September 20, 2021 — ImageCare Centers is unveiling its new “PINK Better Mammo” service with the addition of...
Shimadzu Medical Systems USA, a leading manufacturer of advanced medical X-ray imaging systems, has announced that the Trinias unity edition product line has been awarded a contract from Vizient, Inc., a healthcare performance improvement company, effective Sept. 1, 2021.
News | X-Ray | September 17, 2021
September 17, 2021 — Shimadzu Medical Systems USA, a leading manufacturer of advanced medical...
Avoiding contrast dyes for imaging tests not necessary if concerned about iodine allergy, peer-reviewed study concludes #MRI

Getty Images

News | Contrast Media Injectors | September 16, 2021
September 16, 2021 — FDB (First Databank), a leading provider of drug and medical device knowledge that helps healthc